| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 609.90M | 615.22M | 767.56M | 805.45M | 692.51M | 706.27M |
| Gross Profit | 265.56M | 280.86M | 385.67M | 365.14M | 323.74M | 324.73M |
| EBITDA | -3.60M | -4.93M | 595.82M | 155.33M | 28.98M | 109.05M |
| Net Income | -92.02M | -107.00M | 473.15M | 50.80M | -106.72M | -81.89M |
Balance Sheet | ||||||
| Total Assets | 1.45B | 1.43B | 1.43B | 1.06B | 1.18B | 1.36B |
| Cash, Cash Equivalents and Short-Term Investments | 90.91M | 83.34M | 67.71M | 85.43M | 112.12M | 170.34M |
| Total Debt | 315.39M | 326.62M | 347.18M | 435.62M | 564.90M | 669.32M |
| Total Liabilities | 526.51M | 506.70M | 516.34M | 633.06M | 797.28M | 863.24M |
| Stockholders Equity | 913.91M | 913.23M | 906.58M | 424.05M | 378.15M | 487.52M |
Cash Flow | ||||||
| Free Cash Flow | 69.09M | 16.59M | -31.02M | 54.36M | 83.33M | 181.47M |
| Operating Cash Flow | 73.18M | 24.79M | -593.00K | 61.58M | 92.45M | 185.62M |
| Investing Cash Flow | 40.11M | 54.57M | 147.25M | 112.85M | -9.11M | 104.07M |
| Financing Cash Flow | -89.73M | -61.75M | -174.10M | -198.46M | -138.31M | -330.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.39B | 4.06 | 5.10% | 4.05% | 6.60% | -14.32% | |
73 Outperform | HK$463.75M | 2.83 | 11.02% | 6.00% | 14.52% | 15.74% | |
70 Outperform | HK$1.64B | 4.06 | 10.00% | 9.67% | -9.00% | -21.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$68.76M | 66.32 | 0.34% | ― | 22.40% | 84.62% | |
46 Neutral | HK$67.91M | -0.48 | -10.19% | ― | -13.06% | -120.76% | |
38 Underperform | HK$60.44M | -0.28 | ― | ― | ― | ― |
Stelux Holdings International has issued a supplemental announcement to clarify the intended use of 7,839,000 treasury shares it held as at 31 March 2025 and 30 September 2025. The company now states that these treasury shares are earmarked for potential sale from time to time to raise capital, provided the board considers any such transactions to be in the best interests of shareholders and compliant with Hong Kong Listing Rules and the Companies Ordinance. This move signals that Stelux is keeping an additional funding lever available to support its financial and strategic needs, while confirming that all other information in its latest annual and interim reports remains unchanged.
The most recent analyst rating on (HK:0084) stock is a Hold with a HK$0.06 price target. To see the full list of analyst forecasts on Stelux Holdings International Limited stock, see the HK:0084 Stock Forecast page.